Using adaptive genetic algorithms combined with high sensitivity single cell-based technology to detect bladder cancer in urine and provide a potential noninvasive marker for response to anti-PD1 immunotherapy.

CONCLUSIONS: Using single-cell technology and machine learning; we developed a new assay to distinguish bladder cancer from healthy patients. Future studies are planned to validate this assay. PMID: 31570249 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31570249?dopt=Abstract

Source: Urologic Oncology - September 26, 2019 Category: Urology & Nephrology Authors: Alanee S, Deebajah M, Chen PI, Mora R, Guevara J, Francisco B, Patterson BK Tags: Urol Oncol Source Type: research